PaxMedica, Inc. PXMD shares are trading lower by 38% to $1.09 Monday morning. The company on Monday disclosed the pricing details for its public offering.
The offering consists of over 5 million shares of common stock and corresponding warrants for stock purchase, priced at $1.30 per share. The warrants, exercisable immediately and expiring in five years, accompany the shares.
The offering is expected to close around November 22, pending standard closing conditions. H.C. Wainwright & Co. is the exclusive placement agent for this offering, with projected gross proceeds of approximately $7.0 million before deductions for the placement agent's fees and other expenses.
PaxMedica plans to utilize the net proceeds to repay a convertible promissory note to Lind Global Fund II LP, advance development programs, and for general corporate purposes.
See Also: What's Going On With Microsoft Stock Monday?
According to data from Benzinga Pro, PXMD has a 52-week high of $69.19 and a 52-week low of $1.03.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
